WEBINAR: A Pill for Dystonia? Exploring Vima Therapeutics and the STRIDE Study
October 30 @ 3:00 pm - 4:00 pm
| A Pill for Dystonia? Exploring Vima Therapeutics and the STRIDE Study
Friday, October 30, 2026 | 3 PM Central / 4 PM Eastern | Via Zoom BEBRF welcomes Dr. Naomi Lubarr, Senior Medical Director, and Luke Kramer, Director of Patient Advocacy, from Vima Therapeutics for a special webinar exploring a potential new approach to treating dystonia. They’ll discuss VIM0423, an investigational once-daily oral medication currently being evaluated in the Phase 2 STRIDE clinical study at sites across the United States. Learn more about the research, how clinical trials work, and what this investigational treatment could mean for people living with dystonia. Registration is free and required. |